Jeffrey V. Poulton
Director; EVP, Chief Financial Officer · 5 filings · Latest: Jun 8, 2026
ALNYLAM PHARMACEUTICALS, INC.
CervoMed Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | Mar 4, 2026 | Sale | $323.08 | 2,468 | $797.4K | 61,805 | |
ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | Mar 2, 2026 | Sale | $327.65 | 2,206 | $722.8K | 64,273 | |
ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 27, 2026 | Option Exercise | $0.00 | 1,908 | — | 61,710 | |
ALNY | Jeffrey V. Poulton | EVP, Chief Financial Officer | Feb 13, 2026 | Sale | $310.08 | 2,242 | $695.2K | 59,802 |